caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1043447915

Allison Goddard

PRACTICEALLISON GODDARD, M.D., LLCSee all providers at this practice →
DermatologyFalmouth, MEI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
No data available for this provider in 2024.
REFERRAL NETWORK

Where Allison Goddard's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 11 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
Victor Huang
Dermatology · Sacramento, CA
1150
Refers patients to
Outbound — where patients go next
PhysicianPatientsVisits
BRIGHAM & WOMENS HOSPITAL, INC.187894
DANA-FARBER CANCER INSTITUTE, INC.43210
Christine Lian
Pathology · Worcester, MA
2136
GRANTER, SCOTT1940
Alvaro Laga Canales
Pathology · Boston, MA
1741
SOUTH SHORE HOSPITAL INC.1782
Arash Mostaghimi
Dermatology · Boston, MA
1532
BRIGHAM AND WOMEN'S FAULKNER HOSPITAL, INC14210
Victor Huang
Dermatology · Sacramento, CA
1246
Elizabeth Buzney
Dermatology · Boston, MA
1140
George Murphy
Pathology · Boston, MA
1125
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
PRESCRIBING · PART D · 2024
Total Rx claims
100
Beneficiaries
—
Total drug cost
$75K
Distinct drugs
5
Brand share
16.0%
Top prescribed drugs
Clobetasol Propionate44 claims
Doxycycline Monohydrate16 claims
Apremilast16 claims
Metronidazole12 claims
Triamcinolone Acetonide12 claims
QUALITY · MIPS · 2024
Final MIPS score
86.6
Quality
84.3
Cost
74.5
Improvement activities
40.0
Promoting interop.
0.0
Payment adjustment
0.49%
Group
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$291
Payment records
6
By payment type
Food and Beverage$291